Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.7 |
mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |